| P2093 | author name string | Kazuhiro Watanabe | |
| | Takao Shimizu | |
| | Yosuke Watanabe | |
| | Kiyotaka Kugiyama | |
| | Daisuke Fujioka | |
| | Hideto Mishina | |
| | Jun-ei Obata | |
| | Kenichi Kawabata | |
| | Shun Tamaru | |
| | Takamitsu Nakamura | |
| | Yoshihiro Kita | |
| | Yukio Saito | |
| P2860 | cites work | Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-deficient mice | Q46573266 |
| | Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). | Q46847925 |
| | TNFR1 and TNFR2 signaling interplay in cardiac myocytes. | Q46968897 |
| | Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning | Q47226424 |
| | Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner | Q47388835 |
| | Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats | Q47395547 |
| | Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells, HL60 promyelocytic leukemic cells, and human neutrophils. Evidence for cell type-specific activation of mitogen-activated protein kinases. | Q47827873 |
| | Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. | Q48580352 |
| | Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury. | Q54625811 |
| | Role of phospholipases A2 and C in myocardial ischemic reperfusion injury | Q70112745 |
| | Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion | Q73857227 |
| | Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha | Q77846069 |
| | Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog | Q79495195 |
| | On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes | Q28592582 |
| | Phospholipase A(2). | Q34219384 |
| | New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway | Q34298555 |
| | Properties and regulation of cytosolic phospholipase A2. | Q34430575 |
| | Phospholipase A(2) regulation of arachidonic acid mobilization | Q34980661 |
| | Role of caspases in TNF-mediated regulation of cPLA(2). | Q34980674 |
| | Phospolipase A2 and apoptosis | Q35047115 |
| | Group IV cytosolic phospholipase A2 (PLA2) function: insights from the knockout mouse. | Q35094325 |
| | Secretory phospholipase A2. | Q35860497 |
| | Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited. | Q36182300 |
| | Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis | Q36300832 |
| | Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity | Q36380293 |
| | Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s. | Q36589972 |
| | Control of phospholipase A2 activities for the treatment of inflammatory conditions | Q36595394 |
| | Roles of cPLA2alpha and arachidonic acid in cancer | Q36629023 |
| | Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation | Q37286185 |
| | The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease | Q37679415 |
| | TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure | Q37771751 |
| | Membrane phospholipid metabolism during myocardial ischaemia: past, present and future | Q39672594 |
| | A single intravenous sTNFR-Fc administration at the time of reperfusion limits infarct size--implications in reperfusion strategies in man. | Q40061409 |
| | Myocardial phospholipase A2. | Q41088064 |
| | Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor | Q41553089 |
| | Phospholipase A2-mediated hydrolysis of cardiac phospholipids: the use of molecular and transgenic techniques | Q41740251 |
| | The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning | Q42442474 |
| | Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes | Q42852578 |
| | Deletion of cytosolic phospholipase A2 promotes striated muscle growth | Q44479229 |
| | Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury. | Q44749581 |
| P433 | issue | 10 | |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | H2018-30 | |
| P577 | publication date | 2012-03-16 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway | |
| P478 | volume | 302 | |